Colorectal Cancer Surgery

Introduction

A diagnosis of colorectal cancer brings a great deal to think about at once. There are questions about the operation itself, about whether you will need a stoma (an opening on the abdomen for waste to leave the body), about chemotherapy, about how long recovery will take, and about life afterwards. This guide is written for people who already have a diagnosis of colon or rectal cancer and are preparing for surgery, as well as for families supporting them.

Colorectal cancer surgery is the operation that removes the cancer from the colon (the large intestine) or the rectum (the last part of the bowel before the anus). Major oncology guidelines, including those from the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO), describe surgery as the cornerstone of curative treatment for most early and locally advanced colorectal cancers. For many patients, surgery is combined with chemotherapy or, in rectal cancer, with radiation, as part of a coordinated multimodal plan.

This article explains what the surgery involves, the different types of operations for colon and rectal cancer, the surgical approaches your team may consider, what to expect before and after the operation, the risks involved, and what life looks like in the weeks and months after surgery.

What Is Colorectal Cancer Surgery?

Colorectal cancer surgery is an operation to remove a cancerous tumour from the colon or rectum, along with a margin of healthy bowel on either side and the nearby lymph nodes. The goal is what surgeons call a complete resection with “clear margins” — meaning no cancer cells are seen at the edges of the tissue that has been removed when the pathologist examines it.

A typical operation involves three things:

• Removing the segment of colon or rectum that contains the tumour
• Removing the blood vessels and lymph nodes that drain that segment (this is essential for accurate staging and for reducing the risk of cancer coming back)
• Rejoining the two healthy ends of bowel where possible — this join is called an anastomosis

In some cases the two ends cannot be safely rejoined, or the join needs time to heal. When that happens the surgeon brings a loop of bowel to the surface of the abdomen, creating a stoma. Waste then drains into a bag worn on the skin. A stoma may be temporary (closed by a smaller second operation a few months later) or permanent, depending on where the tumour was and how the surgery went.

The colon and the rectum are part of the same large bowel, but surgically they are treated very differently. The rectum sits deep inside the bony pelvis, surrounded by nerves that control bladder and sexual function, which makes rectal surgery technically more demanding. For this reason, colorectal cancer surgery is best understood as a family of related operations rather than a single procedure.

Why Surgery Is Performed

Surgery is performed with one of two goals: to cure the cancer, or to relieve symptoms when cure is not possible.

Major guidelines describe surgery as the primary curative treatment in:

• Stage I, II, and III colon cancer
• Early-stage rectal cancer
• Locally advanced rectal cancer, usually after chemotherapy and radiation given before surgery (called neoadjuvant therapy)
• Selected cases of stage IV disease where the cancer has spread to a limited number of sites in the liver or lungs that can also be removed

Surgery may also be needed urgently, before a full work-up is possible, if the tumour is causing:

• A bowel obstruction (the bowel is blocked, causing severe pain, vomiting, and inability to pass stool or gas)
• Perforation (a hole in the bowel wall, which is a surgical emergency)
• Significant bleeding from the tumour

In advanced metastatic disease, surgery is not always the main treatment. It may still be used to relieve symptoms such as obstruction or bleeding, or as part of a selected curative strategy when the spread is limited. These decisions are made case by case in a multidisciplinary tumour board, which brings together surgical oncologists, medical oncologists, radiation oncologists, radiologists, and pathologists.

Who Is a Candidate?

Most people with a confirmed diagnosis of colon or rectal cancer that has not spread widely are considered for surgery. The decision involves more than just the cancer itself. Your team will weigh:

• Tumour factors: location, size, stage, depth of invasion into the bowel wall, lymph node involvement, and whether the cancer has spread to other organs
• Patient factors: general health, heart and lung function, nutritional status, age, and any other medical conditions
• Goals: whether the aim is cure, long disease-free survival, or symptom control

For rectal cancer, additional factors matter, including how close the tumour sits to the anal sphincter (the muscle that controls continence). The closer the tumour is to the sphincter, the harder it is to preserve normal bowel function, and the more likely a permanent stoma becomes.

Frailty, poor lung function, advanced heart disease, or severe malnutrition do not automatically rule out surgery, but they may shift the conversation toward less invasive approaches, prehabilitation to improve fitness before surgery, or non-surgical strategies. These trade-offs are best discussed in detail with your surgical and medical oncology team.

Pre-Surgical Evaluation and Staging

Before colorectal cancer surgery, your team will complete a thorough evaluation. Accurate staging — understanding how advanced the cancer is — guides every decision that follows.

Standard investigations include:

• Colonoscopy with biopsy to confirm the diagnosis and identify any other lesions in the colon
• CT scan of the chest, abdomen, and pelvis to look for spread to the liver, lungs, or lymph nodes
• MRI of the pelvis for rectal cancer, to assess how deep the tumour goes and whether it involves nearby structures
• Endorectal ultrasound in some rectal cancer cases, for additional information on tumour depth
• PET-CT scan if there is concern about distant spread that is not clear on other imaging
• Blood tests including a complete blood count, kidney and liver function, and the tumour marker CEA (carcinoembryonic antigen), which gives a baseline for follow-up
• Anaesthesia and cardiac fitness assessment, particularly in older patients or those with heart or lung disease

For rectal cancer, the pelvic MRI is especially important. It helps the team decide whether to give chemotherapy and radiation before surgery to shrink the tumour, improve the chance of clear margins, and reduce the risk of recurrence. This sequencing — treatment before surgery — is the standard for many locally advanced rectal cancers under current NCCN and ESMO guidance.

Your case will typically be discussed in a multidisciplinary tumour board before a plan is finalised. This is where the surgical, medical, and radiation oncology perspectives come together to design treatment that is matched to your specific cancer.

Alternatives and Adjacent Treatments

Surgery is not the only treatment for colorectal cancer, and for some patients it is not the first or even the main treatment. Understanding the alternatives and how they fit together is part of an informed decision.

Endoscopic Removal

Very early colorectal cancers — those still confined to the inner lining of the bowel — can sometimes be removed during a colonoscopy using techniques such as endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD). This avoids open or keyhole surgery entirely. Whether this is possible depends on the size, location, and depth of the lesion, and on findings from the biopsy and imaging.

Watch and Wait After Chemoradiation in Rectal Cancer

Some patients with rectal cancer have such a strong response to chemotherapy and radiation that no visible tumour remains. In selected cases, and in experienced centres, doctors may discuss a “watch and wait” approach with close surveillance rather than immediate surgery. This is an area of active research and is not appropriate for every patient. Whether it is an option in your case depends on careful assessment and the practice of the centre treating you.

Chemotherapy

Chemotherapy is rarely a substitute for surgery in curable disease, but it is a major part of treatment. It may be given:

• Before surgery (neoadjuvant), most often for rectal cancer, sometimes for advanced colon cancer
• After surgery (adjuvant) for stage III colon cancer and selected high-risk stage II cancers, as recommended by ASCO and NCCN guidelines
• As the main treatment in stage IV disease, sometimes alongside targeted therapy or immunotherapy

Radiation Therapy

Radiation is used mainly for rectal cancer, where it improves local control and can shrink the tumour before surgery. It is less commonly used in colon cancer because the colon moves freely within the abdomen, which makes precise targeting difficult.

Targeted Therapy and Immunotherapy

For advanced or metastatic colorectal cancer, treatments that target specific mutations (such as KRAS, BRAF, or HER2) or that use the immune system (immunotherapy for tumours with high microsatellite instability) may form part of the plan. Molecular testing of the tumour helps decide which of these are appropriate.

• Right hemicolectomy: removal of the right side of the colon, used for tumours in the caecum, ascending colon, or hepatic flexure
• Extended right hemicolectomy: includes the transverse colon, used for tumours of the hepatic flexure or proximal transverse colon
• Left hemicolectomy: removal of the left side of the colon, used for tumours of the descending colon
• Sigmoid colectomy: removal of the sigmoid colon, the S-shaped segment just above the rectum
• Subtotal or total colectomy: removal of most or all of the colon, used in selected cases such as multiple tumours or an obstructing right-sided cancer in an unstable patient

In most colon cancer operations, the two healthy ends of bowel are rejoined during the same operation, and a stoma is not needed.

Rectal Cancer Operations

Rectal cancer surgery is more complex because of the narrow space inside the pelvis and the importance of preserving the nerves and muscles that control continence and sexual function. The main operations are:

• Low anterior resection (LAR): removal of the upper and middle rectum, with the colon then joined to the lower rectum or anal canal. The anal sphincter is preserved, so the patient continues to pass stool through the anus. A temporary stoma is often created to protect the join while it heals, and is closed a few months later.
• Abdominoperineal resection (APR): removal of the rectum and the anus together, used when the tumour is very low and the sphincter cannot be preserved. This operation always results in a permanent colostomy.
• Transanal excision: removal of a small, early-stage tumour through the anus, without an abdominal incision. This is only suitable for selected small, early tumours.
• Total mesorectal excision (TME): not a separate operation but a technique applied to LAR and APR. The rectum is removed together with the surrounding fatty envelope (the mesorectum), which contains the lymph nodes. TME, as developed and refined in modern rectal surgery, is considered the standard of care because it significantly reduces the risk of the cancer coming back in the pelvis.

Surgery for Metastatic Disease

When colorectal cancer has spread to the liver or lungs in a limited way, surgery to remove those metastases — called metastasectomy — may be part of a curative plan. This is usually done in coordination with chemotherapy and may be performed at the same time as the bowel operation or in a separate stage.

Surgical Approaches

The same operation can usually be performed in more than one way. The choice of approach depends on the tumour, the surgeon's training and experience, the equipment available at the centre, and the patient's individual situation.

Open Surgery

Open surgery is the traditional approach, using a single longer incision down the middle of the abdomen. It gives the surgeon direct access to the bowel and is still widely used, particularly for:

• Large or locally advanced tumours
• Emergency operations for obstruction or perforation
• Cases with extensive scarring from previous surgery
• Situations where minimally invasive approaches are not feasible or safe

The trade-off is a longer wound, more post-operative pain, and a somewhat longer hospital stay and recovery compared with minimally invasive options.

Laparoscopic Surgery

Laparoscopic surgery, also called keyhole surgery, uses several small incisions through which the surgeon inserts a camera and long instruments. The bowel is mobilised inside the abdomen, then brought out through a slightly larger incision to be removed and rejoined.

Large clinical trials have shown that, for selected colon cancers, laparoscopic surgery achieves cancer control comparable to open surgery, with the added benefits of:

• Smaller scars
• Less post-operative pain
• Earlier return of bowel function
• Shorter hospital stay
• Faster return to normal activities

Laparoscopic rectal surgery is technically more demanding, and the choice between laparoscopic and other approaches for rectal cancer depends heavily on the surgeon's experience and the specific tumour.

Robotic Surgery

Robotic-assisted surgery is a form of minimally invasive surgery in which the surgeon controls instruments through a console. The robotic system provides three-dimensional vision and instruments that can articulate inside narrow spaces. This is particularly useful in the deep, narrow male pelvis when operating on rectal cancer, where access can be difficult with standard laparoscopic instruments.

Robotic surgery offers similar recovery benefits to laparoscopic surgery and may give the surgeon greater precision in selected cases. It requires specialised equipment and training, so availability varies between centres.

Transanal Total Mesorectal Excision (TaTME)

In some specialised centres, surgeons may use a transanal approach to perform TME for low rectal tumours, working partly from below as well as from above. This is a newer technique used in selected cases and selected centres.

No single approach is “best” for every patient. The decision is a clinical one, made together with your surgical oncology team based on the tumour's characteristics and the team's expertise.

Preparing for Surgery

The weeks before surgery are an important window. Many centres now follow Enhanced Recovery After Surgery (ERAS) protocols, which are structured plans designed to improve outcomes and shorten recovery. Preparation typically includes:

• Prehabilitation: simple measures to improve fitness before surgery, such as walking daily, breathing exercises, and improving nutrition. Even a few weeks of preparation can make a real difference to recovery.
• Nutritional support: if you have lost weight or are eating poorly because of the tumour, you may be given nutritional supplements before surgery.
• Stopping smoking and limiting alcohol: both improve wound healing and reduce complications.
• Medication review: some medicines, particularly blood thinners, diabetes medications, and certain herbal supplements, may need to be paused or adjusted.
• Bowel preparation: depending on the operation and the surgeon's practice, you may be asked to take laxatives the day before surgery to empty the bowel, sometimes combined with oral antibiotics. Approaches vary.
• Stoma marking: if a stoma is planned or possible, a specialised stoma nurse will meet with you before surgery to mark the best position on your abdomen. This greatly improves the practicality of living with a stoma afterwards.
• Counselling and consent: a detailed discussion of what is planned, what could go wrong, and what to expect during recovery.

If you are likely to need a stoma, even temporarily, learning about stoma care before surgery makes the experience much less overwhelming afterwards.

What Happens During Surgery

Colorectal cancer surgery is performed under general anaesthesia, meaning you are fully asleep throughout. The operation typically lasts between two and five hours, depending on the location of the tumour, the approach used, and the complexity of the case.

A typical sequence is:

• Anaesthesia is given, along with antibiotics to prevent infection and measures to prevent blood clots
• The surgeon makes the incisions appropriate to the approach (one larger incision for open surgery, several smaller ones for laparoscopic or robotic surgery)
• The bowel is examined and the tumour located
• The blood vessels supplying that segment of bowel are carefully tied off
• The affected segment of bowel, along with the lymph nodes that drain it, is removed in one piece
• The two healthy ends of bowel are rejoined where possible, using stitches or surgical staples
• If a stoma is needed, a loop of bowel is brought to the surface of the abdomen and stitched in place
• The abdomen is checked for bleeding, washed out, and closed

The removed tissue is sent to the pathology laboratory, where it is examined to confirm the diagnosis, check the margins, and count the lymph nodes. This final pathology report — which is usually ready within one to two weeks — is what tells you and your team the true stage of the cancer and whether further treatment is recommended.

Recovery in Hospital

The hospital stay after colorectal cancer surgery typically ranges from three to seven days, sometimes longer for complex operations or if complications arise. Minimally invasive surgery is usually associated with a shorter stay than open surgery.

Under ERAS protocols, the focus is on helping you recover quickly through:

• Early mobilisation: sitting out of bed on the day of surgery or the next day, walking with help soon after
• Pain management: using a combination of medications to control pain while limiting strong opioids, which can slow bowel recovery
• Early eating and drinking: sipping fluids on the day of surgery and gradually building up to a normal diet over the following days
• Removing tubes early: urinary catheters and drains are removed as soon as it is safe
• Breathing exercises: to reduce the risk of chest infections
• Blood clot prevention: with compression stockings and small injections of blood thinners

Signs that recovery is going well include passing gas (a sign that the bowel is “waking up”), tolerating food, walking confidently, and managing pain with oral medications. If you have a stoma, a stoma nurse will teach you and a family member how to care for it before you go home.

Recovery at Home

• First 2 weeks: wound healing, light walking, gentle activity at home, frequent rest
• 2 to 4 weeks: gradual return of energy, longer walks, light household activities
• 4 to 6 weeks: return to most light activities; many people can return to office-based work after this point
• 6 to 8 weeks or longer: full recovery for open surgery; heavy lifting and strenuous exercise resume after this
• 3 to 6 weeks: typical recovery for laparoscopic or robotic surgery, though individual recovery varies

Some general expectations during this period:

• Bowel habits often change for several weeks or months. After rectal surgery in particular, more frequent stools, urgency, or difficulty emptying completely (sometimes called “low anterior resection syndrome”) are common and tend to improve over time.
• Fatigue is normal and may last several months, especially if chemotherapy follows surgery.
• Appetite may take time to return; small, frequent meals are easier to tolerate than large ones.
• Driving is usually safe once you can comfortably perform an emergency stop and are off strong painkillers — check with your surgical team.
• Sexual activity can resume when you feel ready, typically after a few weeks; rectal surgery in particular can affect sexual function and any concerns are worth raising with your team.

If chemotherapy is planned, it usually begins between four and eight weeks after surgery, once you have recovered sufficiently.

Living with a Stoma

• Colostomy: made from the colon, usually on the left side of the abdomen. Output is more formed.
• Ileostomy: made from the small intestine, usually on the right side. Output is more liquid and more frequent.

A stoma nurse plays a central role before and after surgery, teaching you how to change the pouch, care for the skin around the stoma, manage diet, and recognise problems. Most people, with time and support, return to work, travel, exercise, and intimate relationships with a stoma. The first few weeks involve a learning curve; it gets easier.

If your stoma is temporary, a smaller second operation (stoma reversal) is usually performed two to six months later, once the main surgery has healed and any planned chemotherapy is complete.

Risks and Complications

All major abdominal surgery carries risks. Modern surgical techniques, careful patient selection, and ERAS protocols have reduced these significantly, but they cannot be eliminated. Your surgical team will discuss the specific risks for your operation. The main ones include:

• Anastomotic leak: the most serious specific complication, where the join between the two ends of bowel leaks fluid into the abdomen. This may require antibiotics, drains, or a return to the operating room. The risk varies with the location of the join — it is higher for low rectal joins than for colon joins.
• Wound infection: the most common complication, treated with wound care and antibiotics
• Bleeding: usually controlled during the operation; occasionally requires transfusion or further surgery
• Blood clots in the legs or lungs: reduced by early mobilisation and blood-thinning injections
• Chest infections: reduced by breathing exercises and early mobilisation
• Bowel obstruction: from internal scarring (adhesions), which can occur weeks, months, or years after surgery
• Urinary problems and sexual dysfunction: particularly after rectal surgery, due to the proximity of nerves controlling these functions
• Stoma-related problems: skin irritation, leaks, retraction, or hernia around the stoma
• Hernia at the incision site (incisional hernia): a later complication that may need separate repair

Outcomes are generally better when surgery is performed by experienced colorectal surgeons working within high-volume centres with structured peri-operative care.

Adjuvant Treatment After Surgery

The pathology report from your surgery gives the final stage of the cancer and guides any further treatment. Major guidelines, including those from NCCN, ASCO, and ESMO, describe the following general patterns:

• Stage I: usually no further treatment is needed after surgery
• Stage II: chemotherapy may be discussed if there are high-risk features such as tumour perforation, obstruction, fewer than a recommended number of lymph nodes examined, or unfavourable tumour biology
• Stage III colon cancer: adjuvant chemotherapy is standard, typically given over three to six months
• Rectal cancer: the sequence of chemotherapy, radiation, and surgery depends on the stage and is often decided before surgery. Total neoadjuvant therapy — giving all chemotherapy and radiation before surgery — is an increasingly common pattern in locally advanced rectal cancer.
• Stage IV: chemotherapy, sometimes with targeted therapy or immunotherapy, is the main treatment, with surgery used selectively

Adjuvant treatment is shown in clinical studies to reduce the risk of cancer returning and to improve long-term survival in the stages where it is indicated.

Outcomes and What to Expect Long Term

Outcomes after colorectal cancer surgery depend primarily on the stage at diagnosis, the completeness of the surgery (clear margins, adequate lymph node sampling), the biology of the tumour, and access to appropriate adjuvant treatment.

In general terms:

• Early-stage disease (stage I and many stage II cancers) has a high chance of long-term cure with surgery alone or surgery plus selected chemotherapy
• Stage III disease has a meaningful chance of long-term cure when surgery is combined with adjuvant chemotherapy
• Stage IV disease has historically had poorer outcomes, but a subset of patients with limited spread to the liver or lungs can achieve long-term remission with combined treatment, and modern systemic therapy has extended survival significantly

Specific survival numbers vary by population, by stage subdivision, and by tumour biology, and the most accurate estimate for your situation will come from your oncology team after the final pathology report. Early detection through screening, accurate staging, expert surgery, and access to multimodal treatment all improve outcomes.

Follow-Up and Surveillance

After surgery, structured follow-up is important for detecting any recurrence early, managing late effects of treatment, and supporting recovery. A typical surveillance plan for the first five years includes:

• Clinical review every three to six months for the first two to three years, then every six to twelve months
• CEA blood test at each follow-up visit (a rising CEA can be an early sign of recurrence)
• CT scans of the chest, abdomen, and pelvis, typically once a year for the first three to five years
• Colonoscopy at intervals defined by guidelines — usually one year after surgery (or earlier if a complete colonoscopy was not possible before), then at intervals depending on findings

The exact schedule is tailored to your stage, the operation you had, and any other findings. Beyond five years, surveillance often becomes less frequent but does not stop completely.

Follow-up is also when late effects of treatment — bowel changes, sexual function, fatigue, stoma issues, emotional impact — are picked up and managed. Many cancer centres now include dedicated survivorship clinics for this purpose.

Emotional and Practical Considerations

The emotional impact of a cancer diagnosis and major surgery is significant. It is common to feel anxious before the operation, low or tearful in the early weeks of recovery, and uncertain about the future during follow-up. These feelings tend to ease with time, but they are real and worth talking about.

Practical points that often help include:

• Identifying a single family member or friend who can come to key appointments and help track information
• Asking the team to put the treatment plan in writing
• Connecting with a stoma nurse early if a stoma is planned or possible
• Speaking with a dietitian for advice on eating well during and after treatment
• Looking into patient support groups, where talking to others who have been through the same experience can be deeply helpful
• Raising any concerns about sexual function, body image, or mental health with your team — these are part of recovery, not separate from it

If anxiety or low mood is persistent or interferes with daily life, asking your team for a referral to a psychologist or counsellor experienced in cancer care is a reasonable step.

Frequently Asked Questions

Will I definitely need a stoma?

No. Most colon cancer operations do not require a stoma. For rectal cancer, the chance of needing a stoma depends mainly on how close the tumour is to the anal sphincter. Many stomas are temporary and closed by a second smaller operation a few months later. Your surgical team will give you a realistic picture before surgery based on imaging and examination.

How long does the surgery take?

Most colorectal cancer operations take between two and five hours, depending on the location of the tumour, the approach used, and the complexity of the case.

How long will I stay in hospital?

Typical stays are three to seven days, often shorter after laparoscopic or robotic surgery and longer after complex open surgery or if complications occur.

When can I go back to work?

Many people return to office-based work between four and six weeks after surgery. Physically demanding work usually takes longer — often eight to twelve weeks. If you are having chemotherapy afterwards, this may extend the timeline. Your surgical team can give you a personalised estimate.

Will I need chemotherapy after surgery?

This depends on the final pathology report and the stage of the cancer. Major guidelines describe chemotherapy as standard for stage III colon cancer and for selected high-risk stage II cancers. For rectal cancer, the sequence is often different, with treatment before surgery. The medical oncology team will discuss the recommendation with you once the pathology is available.

What is the chance the cancer will come back?

This depends on the stage, the completeness of the surgery, the biology of the tumour, and whether adjuvant treatment is given. Early-stage cancers have a relatively low chance of recurrence; more advanced cancers have a higher chance. Your team can give you the most accurate estimate after the pathology report is complete.

Can I live a normal life after a stoma?

Yes. Most people with a stoma return to work, travel, exercise, social activities, and intimate relationships. The first few weeks involve learning new routines, and a stoma nurse provides essential support during this period.

Is laparoscopic or robotic surgery better than open surgery?

For selected colon cancers, minimally invasive surgery has been shown in large clinical studies to give equivalent cancer outcomes with quicker recovery. For rectal cancer, the choice is more nuanced and depends on the tumour and the surgeon's experience. There is no single “best” approach for every patient; the decision is made together with your surgical oncology team.

What does the CEA blood test mean?

CEA is a protein that can be raised in colorectal cancer. It is used as a tumour marker. A baseline is taken before surgery, and CEA is then checked at follow-up visits. A rising CEA can be an early sign that the cancer is returning and prompts further investigation, though it is not a perfect marker and is always interpreted together with scans and clinical findings.

Conclusion

Colorectal cancer surgery is a major operation, but it is one with a long track record of curing or controlling cancer when performed at the appropriate stage and combined with the right additional treatments. Advances in minimally invasive techniques, enhanced recovery protocols, and multidisciplinary planning have made the operation safer and recovery quicker than in the past.

The right operation for any individual patient depends on where the tumour is, how advanced it is, the patient's general health, and the practice of the treating team. Decisions about the type of surgery, the approach, the role of chemotherapy and radiation, and whether a stoma is needed are clinical judgments made together with your surgical and medical oncology team, informed by current guidelines from bodies such as NCCN, ASCO, and ESMO.

Going into the operation with a clear understanding of what to expect — the surgery itself, the recovery, the possibility of a stoma, the role of adjuvant treatment, and the long arc of follow-up — helps you participate fully in decisions and prepare practically and emotionally for the months ahead.